Nomura Asset Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1751 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1784 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1711 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1716 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1734 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1724 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1742 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1759 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1761 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1257 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1245 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1271 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1276 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1239 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1044 |
|